About the Authors
- Ørnulf Paulsen
-
* E-mail: ornulf.paulsen@sthf.no
Affiliations Department of Cancer Research and Molecular Medicine, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU), Trondheim, Norway, Palliative Care Unit, Telemark Hospital Trust, Skien, Norway
- Barry Laird
-
Affiliations Department of Cancer Research and Molecular Medicine, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU), Trondheim, Norway, Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, United Kingdom
- Nina Aass
-
Affiliations Faculty of Medicine, University of Oslo, Oslo, Norway, Department of Oncology, Oslo University Hospital, Oslo, Norway
- Tor Lea
-
Affiliation Department of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, Ås, Norway
- Peter Fayers
-
Affiliations Department of Cancer Research and Molecular Medicine, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU), Trondheim, Norway, Department of Public Health, University of Aberdeen, Aberdeen, United Kingdom
- Stein Kaasa
-
¶‡ These authors are joint senior authors on this work.
Affiliations Department of Cancer Research and Molecular Medicine, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU), Trondheim, Norway, Faculty of Medicine, University of Oslo, Oslo, Norway, Department of Oncology, Oslo University Hospital, Oslo, Norway
- Pål Klepstad
-
¶‡ These authors are joint senior authors on this work.
Affiliations Department of Cancer Research and Molecular Medicine, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU), Trondheim, Norway, Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway, Department of Anesthesiology and Intensive Care Medicine, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
Competing Interests
Stein Kaasa has served as a consultant on an Advisory board for, and his institution has received unrestricted grants from, Helsinn. Barry Laird has served as a consultant on advisory boards for Chugai and Pfizer. The other authors have no potential conflicts of interest to disclose. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: ØP BL SK PK. Formal analysis: ØP PF PK. Funding acquisition: ØP. Investigation: ØP NA SK. Methodology: ØP BL PF SK PK. Project administration: ØP. Resources: ØP TL NA SK. Software: ØP PF PK. Supervision: BL NA PK SK. Validation: ØP PK SK. Writing – original draft: ØP BL PK SK. Writing – review & editing: ØP BL NA TL PF SK PK.